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Abstract
Orbiviruses form the largest genus of the family Reoviridae consisting of at least 23 different virus species. One of these is
the bluetongue virus (BTV) and causes severe hemorrhagic disease in ruminants, and is transmitted by bites of Culicoides
midges. BTV is a non-enveloped virus which is released from infected cells by cell lysis and/or a unique budding process
induced by nonstructural protein NS3/NS3a encoded by genome segment 10 (Seg-10). Presence of both NS3 and NS3a is
highly conserved in Culicoides borne orbiviruses which is suggesting an essential role in virus replication. We used reverse
genetics to generate BTV mutants to study the function of NS3/NS3a in virus replication. Initially, BTV with small insertions in
Seg-10 showed no CPE but after several passages these BTV mutants reverted to CPE phenotype comparable to wtBTV, and
NS3/NS3a expression returned by repair of the ORF. These results show that there is a strong selection for functional NS3/
NS3a. To abolish NS3 and/or NS3a expression, Seg-10 with one or two mutated start codons (mutAUG1, mutAUG2 and
mutAUG1+2) were used to generate BTV mutants. Surprisingly, all three BTV mutants were generated and the respective
AUGMetRGCCAla mutations were maintained. The lack of expression of NS3, NS3a, or both proteins was confirmed by
westernblot analysis and immunostaining of infected cells with NS3/NS3a Mabs. Growth of mutAUG1 and mutAUG1+2 virus
in BSR cells was retarded in both insect and mammalian cells, and particularly virus release from insect cells was strongly
reduced. Our findings now enable research on the role of RNA sequences of Seg-10 independent of known gene products,
and on the function of NS3/NS3a proteins in both types of cells as well as in the host and insect vector.
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Introduction
Orbiviruses form the largest genus of the family Reoviridae
consisting of at least 23 virus species [1]. Three of these orbivirus
species, bluetongue virus (BTV), epizootic haemorrhagic disease
virus (EHDV), and African horsesickness virus (AHSV) cause a
‘notifiable disease’ as listed by the Office International des
Epizooties (OIE) [2]. Virus transmission between ruminants
(BTV and EHDV) or equids (AHSV) occurs in majority by bites
of specific species of Culicoides. BTV is causing severe haemor-
rhagic disease in ruminants with fever, lameness, coronitis,
swelling of the head (particularly the lips and tongue) and death.
BTV has been the most extensively studied orbivirus and serves as
representative of arthropod-borne orbiviruses. Twenty-four sero-
types of BTV have been recognized as defined by cross-
neutralization assays, and recent BTV isolates are considered as
serotype 25 and 26 which was partially based on sequence data
[3,4].
The genome of orbiviruses consist of ten linear double-stranded
RNA genome segments (Seg-1 to Seg-10) encoding structural
proteins VP1 to VP7, non-structural proteins, NS1, NS2 and
NS3/NS3a, for reviews see [5,6], and the recently discovered non-
structural protein NS4 of BTV [7,8]. The virus particle composes
three shells of proteins. The inner shell consists of VP3 encoded by
Seg-3, the middle shell consists of VP7 encoded by Seg-7, and the
outer shell is formed by VP2 (Seg-2) and VP5 (Seg-6). The
orbivirus particle further contains enzymatic proteins VP1 (Seg-1),
VP4 (Seg-4) and VP6 (Seg-9), and one copy of each of the ten
genome segments in the inner shell. The non-structural proteins
NS1 (Seg-5), NS2 (Seg-8), NS3/NS3a (Seg-10), and NS4 (Seg-9)
are not part of the virus particle.
Cell lysis is considered as the predominant mechanism in the
release of non-enveloped viruses into the environment. As for
other non-enveloped viruses like SV40 [9] and poliovirus [10],
complex trafficking and budding strategies are also involved in
release of orbiviruses which is likely mediated by the NS3/NS3a
protein. BTV releases the cell by both mechanisms of which cell
lysis is the major mechanism in mammalian cells, whereas no cell
lysis after infection of insect cells has been observed [11,12,13].
Virus release occurs by budding of the cell membrane therewith
acquiring a temporary envelope or by disruption of the cell
membrane. Non-lytic release of progeny virus from infected cells
has been supposed to be mediated by NS3/NS3a encoded by Seg-
10 [14]. In contrast to expression in mammalian cells, NS3/NS3a
is highly expressed in Culicoides cells. Remarkably, NS3/NS3a of
the non-enveloped orbiviruses are membrane associated glycosy-
lated proteins [15]. The proteins contain two transmembrane
regions flanked by a long N-terminal and short C-terminal
cytoplasmic domain, and a small extracellular domain with a
highly conserved N-glycosylation site between both membrane
regions (Fig. 1). Further, the N-terminal part of NS3, not present
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in NS3a, interacts with cellular release factors calpactin S100A10/
p11 and Tsg101, whereas the C-terminal domain binds VP2 on
the outside of the virus particle [16,17,18]. The amino acid
sequence of NS3/NS3a varies however considerably between and
within different orbivirus species, but the abovementioned motifs
and domains are well conserved. The function of NS3a of
orbiviruses remains unclear, although the second in-frame start
codon of NS3a is completely conserved in the major arthropod-
borne orbivirus species, suggesting an important role for NS3a in
the mammalian or insect cell.
NS3/NS3a protein exhibits viroporin-like properties, and these
proteins have been extensively studied to elucidate their role in
virus replication [19]. NS3/NS3a complementing cell lines have
been used to produce NS3/NS3a mutants of BTV suggesting an
essential role in BTV replication in mammalian cells [17].
Recently, reverse genetics for cell-adapted BTV1, vaccine virus
for serotype 6 as well as for virulent BTV8 has been developed
[20,21]. Here, we have used reverse genetics to generate NS3/
NS3a mutant viruses to investigate the role of NS3/NS3a in BTV
replication. Both NS3 and NS3a seemed to be involved in virus
release from insect cells, whereas this effect was less obvious for
NS3a in mammalian cells. More importantly, although considered
to be essential, expression of NS3 and NS3a is not required for
virus propagation in both mammalian and insect cells.
Materials and Methods
Cell Lines, Viruses, and Antibodies
BSR cells (a clone of BHK-21 cells [22]) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) con-
taining 5% fetal bovine serum (FBS), 100 IU/ml penicillin,
100 mg/ml streptomycin and 2,5 ug/ml Amphotericin B.
C. variipennis (KC) cells [13] were grown in modified Schneider’s
Drosophila medium with 15% heat inactivated foetal bovine
serum, 100 IU/ml penicillin and 100 mg/ml streptomycin.
Figure 1. Schematic representation of BTV NS3 and putative amino acid sequences of mutant viruses. (A) Schematic representation of
BTV NS3. Numbers indicate amino acid position according to the NS3 amino acid sequence The two cytoplasmic domains (IC), the two
transmembrane domains (TM; yellow), the extracellular domain (EC; orange), the calpactin S100A10/p11 binding site (blue), the late domain motifs
(LD; green), the VP2 binding domain (VP2 BD: red), and the conserved N-linked glycosylation site at position 150 (NLG) are indicated. (B) NS3 is an
integral membrane protein that interacts to cellular release factors calpactin S100A10/p11 and Tsg101, whereas the C-terminal domain binds VP2 on
the outside of the virus particle. (C) The putative amino acid sequence in the regions of the StyI, BsiWI sites and StyI-filled or BsiWI-filled are shown in
single letter code. Changed amino acids by a 4-basepairs insertion are underlined. (D) Single and double AUGRGCC mutations are shown. Dots and
dashes indicate no change and absence of expression, respectively.
doi:10.1371/journal.pone.0085788.g001
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All viruses used in this study were generated by reverse genetics.
Virus stocks were obtained by infection of BSR cells at low
multiplicity of infection (MOI) and harvested when 100%
cytopathogenic effect (CPE) was observed. Virus titers were
determined by endpoint dilution and were expressed as 50% tissue
culture infective dose (10logTCID50/ml). Virus stocks were stored
at 280uC.
Monoclonal antibody (Mab) directed against BTV-VP7 was
produced by hybridoma ATCC-CRL-1875 (American Type
Culture Collection). Mabs 32b6, 32h2 and 32f1 directed against
NS3 were a gift from Ingenasa, Spain. Polyclonal antibodies (Pabs)
against VP5 (gift from Michiel Harmsen CVI-Lelystad) were
raised against peptide 208–245 of BTV8-VP5 (Genscript corpo-
ration; Piscataway, NJ).
Construction of Mutant Genes of Seg-10
Mutations in Seg-10 of BTV8 [21] were introduced by filling in
the recognition sites for StyI (at nucleotide position 129) or BsiWI
(at nucleotide position 259) with Klenow large fragment of DNA
polymerase followed by ligation resulting in a 4-basepairs
insertion. Start codons 1 and 2 were mutated (AUGRGCC) in
Seg-10 of BTV8. Therefore, cDNAs of fragments containing the
AUGRGCC mutation (mutAUG1 or AUG2) were synthesized by
Genscript corporation (Piscataway, NJ) and cloned in pUC57.
These fragments were exchanged in pUC57 containing Seg-10 of
BTV8 by standard methods resulting in mutAUG1 and
mutAUG2 under control of the T7 RNA-polymerase promoter
and a recognition site for a restriction enzyme at the 39-terminus
for defined run-off transcription. Start codon mutations were
combined by exchange of the BstBI fragment of mutAUG2 in the
plasmid containing mutAUG1 resulting in mutAUG1+2.
All cDNAs were completely sequenced to confirm the sequence
and respective start codon mutations. Plasmids were maintained in
E.coli DH5a, and were purified using the QIAfilter Plasmid Midi
Kit (Qiagen).
Rescue of BTV from RNA Transcripts
T7-derived RNA transcripts from linearized plasmids were
synthetized and generating of BTV was performed as previously
described [21]. Briefly, monolayers of 105 BSR cells per 2 cm2
were transfected with equimolar amounts of RNA of BTV
segments encoding VP1, VP3, VP4, NS1, VP6, NS2. In total,
600 ng RNA was transfected using 1,5 ml lipofectamineTM 2000
(1:2.5; 1 mg/ml Invitrogen) in Opti-MEMH I Reduced Serum
Medium according to manufacturer’s conditions. Eighteen to
twenty hours post transfection, monolayers were transfected again
with 600 ng equimolar amounts of ten BTV RNA segments. BTV
mutants were rescued from T7-derived RNA transcripts using
Seg-1 to 9 from BTV1 completed with Seg-10 (mutated) RNA
from BTV8. Supernatants were harvested from monolayers 48 h
after the second transfection. Cytopathogenic effect (CPE) specific
for BTV was confirmed by immunostaining of fixed monolayers
with VP7 directed Mab CRL-1875 according to standard
procedures. If no clear CPE was observed, but immunostaining
was positive, duplicate wells were passed in 1:5 dilution and
screened for BTV replication by CPE and/or immunostaining.
Sequencing of Seg-10
Viral RNA was isolated from 200 ml of virus stocks with the
High Pure Viral RNA kit (Roche). Seg-10 was amplified with
primers NS3-S10f* (59-GTTAAAAAGTGTCGCTGCC-39) and
NS3-S10r (59-GTAAGTGTGTAGTGTCGCGCAC-39). Six ml
of RNA was denaturated at 94uC for 3 min and immediately
cooled on ice. A one-step RT-PCR kit (Qiagen) was used to
reversely transcribe RNA and subsequently cDNA was amplified
in a RT-PCR containing both primers. The reaction mix
contained 10 ml of 56QIAGEN one-step RT-PCR buffer, 2 ml
of dNTP mix, 0.6 mM of each primer and 2 ml of the enzyme mix
(containing RT and PCR reaction enzymes). RNase-free water
was added to a total volume of 44 ml. Six microliters of denatured
RNA was added to the mix. The RNA was reversely transcribed at
45uC for 30 min. This was followed by an activation step at 94uC
for 15 min. Forty amplification cycles were then carried out (94uC
for 1 min, 45uC for 1 min and 72uC for 2 min, followed by a
terminal extension step at 72uC for 10 min. The cDNA products
were analyzed by 0.9% agarose gel electrophoresis and visualized
under UV light after staining with ethidium bromide.
Amplicons were completely sequenced to confirm Seg-10
sequences using appropriate primers and the BigDyeH Terminator
v1.1 Cycle Sequencing Kit in a ABI PRISMH 3130 Genetic
Analyzer (both supplied by Applied Biosystems, Foster City, IA,
USA).
Growth Curve on BSR and KC Cells
Confluent BSR- or KC-monolayers in M24-well plates were
infected in duplicate at a multiplicity of infection (MOI) of 0.01.
After attachment to cells for 1.5 h at 37uC, the medium was
removed (and washed once) and refreshed with 1 ml of DMEM
complete medium (see cell lines) and incubation was continued. At
6, 16, 24, 30, 40, 72 and 96 h post infection (hpi), supernatants
and cells were separated, harvested and stored at 280uC. Virus
titers were determined by endpoint dilution on BSR cells
expressed as tissue culture infective doses (10logTCID50/ml).
Therefore, BSR cells were infected with tenfold dilutions of
samples, and grown for 72 h. Positive wells were detected by
immunostaining with VP7-specific Mab ATCC-CRL-1875.
Plaque Morphology of BTV on BSR Cells
BSR monolayers were infected by tenfold dilutions of indicated
viruses, and grown for 48 h under overlay medium (K1000
complete with 1% methylcellulose). Monolayers were fixed with
methanol/acetone (1:1) and immunostained with Mab ATCC-
CRL-1875. Plaques in appropriate dilutions were compared.
Western Blot Analysis of NS3/NS3a Proteins
BSR cells were infected with indicated viruses with an MOI of
0.1. Lysates were prepared from 25 cm2 flasks with beginning CPE
throughout the whole monolayer. Therefore, cells were lysed in
2 ml PBS containing 1% NP40 and protease inhibitor cocktail
complete (Roche, 1 tablet/10 ml lysis buffer). Cell debris was
removed by centrifugation 59 4000 rpm at 4uC. For western
blotting, lysates were concentrated using Amicon UltracelH 10K
spin columns (Millipore). Ten ml samples in LDS buffer (NuPAGE)
with reducing agent (NuPAGE) were heated for 29 at 70uC and
separated by electrophoresis on a 12% BIS-TRIS polyacrylamide-
gel in 16 MOPS-SDS buffer using the XCell-Surelock system.
Separated proteins were transferred to nitrocellulose paper.
Transferred proteins were incubated with Mabs/Pabs and as
second antibody horse-radish peroxidase (HRPO)-conjugated
rabbit a-mouse (for Mabs against BTV-NS3), goat a-rabbit (for
Pabs against BTV-VP5) and rabbit a-goat (for goat serums against
BTV8) were used according to manufacturer’s conditions. Bound
conjugates were detected with Supersignal (Pierce) by exposure to
medical X-ray films (Fuji).
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Results
Repair of NS3/NS3a Expression in BTV Mutants
The role of different domains of NS3/NS3a (Fig. 1a) in
trafficking and egress of BTV was studied by 4-basepairs insertions
at different positions in Seg-10. Filling in of the StyI site resulted in
truncated NS3/NS3a at amino acid position 56 (Fig. 1C) located
in the first of the two late domain motifs. Similarly, a 4-basepairs
insertion was introduced at the BsiWI site resulting in truncated
NS3/NS3a at position 88 (Fig. 1C) between the late domain and
the first transmembrane region. Using these mutated segments in
reverse genetics to generate BTV mutants no CPE was detected
two days after the second RNA transfection (2 dpt). However, cells
were immunostained with VP7 Mab indicating expression of viral
proteins (Fig. 2A; 2 dpt). Transfected cells of duplicate wells were
passaged and at 8 dpt distinct plaques of immunostained cells were
visible for both Seg-10 mutants suggesting BTV replication. After
a subsequent passage, CPE was shown for the Sty-filled mutation in
Seg-10 (Fig. 2A; 13 dpt). Sequencing of Seg-10 of this passage
showed a point deletion resulting in repair of the open reading
frame (ORF) of NS3/NS3a thereby inserting an Alanine at
position 38 of NS3 (StyI-rev1, Fig. 2B). Reverse genetics with this
mutated Seg-10 was repeated and a BTV revertant was generated
again after the same number of passages (StyI-rev2). Sequence
results showed again that the ORF of NS3/NS3a was restored by
a point deletion. The putative amino acid sequence of mutated
NS3/NS3a of StyI-rev2 compared to wild type NS3/NS3a
showed, in addition to an extra alanine, a double amino acid
mutation (PPRHQ) (Fig. 2C). Noteworthy, the conserved first late
domain motif PPRY was mutated in both StyI-revertants.
Duplicate wells of the BsiWI mutated Seg-10 were also
passaged, since cells were consistently immunostained suggesting
BTV replication. The BsiWI-filled mutant reverted from non-CPE
to CPE phenotype in nine subsequent passages. Sequencing of
Seg-10 revealed a point deletion, resulting in restoration of the
ORF of NS3/NS3a by insertion of valine at position 82 and one
amino acid change (ARR) at position 83 (Fig. 2C). Apparently,
BTV replication strongly favours expression of NS3/NS3a, since
4-basepairs insertions in the ORF were restored and virus was
rescued which was associated with a phenotypical change from
non-CPE to CPE despite of several amino acid mutations.
NS3 and NS3a are not Essential for BTV Replication
In order to study the role of NS3 and NS3a in BTV replication,
expression of NS3 and NS3a from Seg-10 was separated by single
AUGRGCC mutations in Seg-10 (mutAUG1 and mutAUG2,
respectively). In addition, both start codon mutations were
mutated to study the role of both proteins (mutAUG1+2).
MutAUG1 would not lead to expression of NS3 but only NS3a
and mutAUG2 would only express NS3and not NS3a, whereas
mutAUG1+2 will not translate both NS3 and NS3a protein
(Fig. 1D). All three mutated Seg-109s were used to generate BTV
mutants using reverse genetics. At 2 dpt clear CPE was observed
for mutAUG2, whereas delayed CPE was observed after further
passaging of transfected cells (p2) for mutAUG1. Similarly,
mutAUG1+2 virus was detected in supernatant of transfected
cells at 8 dpt after two passages of transfected cells. Delayed CPE
similar to mutAUG1 was observed in BSR cells for mutAUG1+2
after infection of fresh monolayers. Surprisingly, all three BTV
mutants were generated from which we conclude that neither NS3
nor NS3a is essential for BTV propagation.
Extensive studies were performed to confirm the absence of
both proteins in propagated BTV mutants.
Sequence analysis of entire Seg-10 RNA isolated from
supernatants containing infectious BTV confirmed the presence
of the respective AUGRGCC mutations in all three BTV
mutants. (Fig. 3A). BTV mutants were reproducibly generated,
and only one out of three mutAUG1 virus stocks showed an
additional point mutation at position 486 in Seg-10 resulting in a
VRA mutation at aa position 156 of NS3. This amino acid
mutation did not result in a difference in plaque size (data not
shown). All other independently generated AUG mutant viruses
did not contain additional mutations in Seg-10.
Expression of NS3 and/or NS3a in infected cells was detected
by immunostaining with NS3/NS3a specific Mabs for both single
start codon mutations, but not for mutAUG1+2 virus. Infection of
mutAUG1+2 virus was however confirmed by immunostaining
with anti-VP7 Mab (Fig. 3B). NS3/NS3a expression was further
investigated in concentrated lysates by western blotting using anti-
NS3/NS3a Mabs. Cells infected with mutAUG1 virus expressed a
protein comigrating with the smaller band (NS3a) of the two NS3-
related proteins expressed in BSR cells infected with wtBTV1/8
(S10) (Fig. 4, left panel lanes 1 and 2). Cells infected with
mutAUG2 virus only expressed NS3 comigrating with the larger
NS3-related protein (Fig. 4, left panel lanes 1 and 3). No NS3-
related proteins were detected in cells infected with mutAUG1+2
virus indicating that truncated forms of NS3 were not expressed
(Fig. 4, left panel, lane 4). Further, lanes 1–3 with NS3-related
proteins showed protein bands of higher molecular weight
representing different forms of the carbohydrate groups of NS3/
NS3a (lane 1–3). The protein bands were not present in lane 4
(mutAUG1+2) confirming that this BTV mutant is not expressing
NS3/NS3a or any other truncated form of NS3. VP5 protein was
detected in all (wtBTV1/8(S10), mutAUG1, mutAUG2 and
mutAUG1+2) infected cells demonstrating expression and detec-
tion of virus proteins, and confirmed infection by the respective
BTV mutants (Fig. 4, right panel, lanes 1–4).
NS3 and NS3a are Involved in Cytopathogenic Effect and
Virus Release
A clear difference in CPE was observed between wtBTV1/
8(S10) and mutAUG2 compared to mutAUG1 and mutAUG1+2
(Fig. 3b). These two groups of two viruses also differ in expression
of NS3; wtBTV1/8(S10) and mutAUG2 are expressing NS3,
whereas mutAUG1 and mutAUG1+2 are not expressing NS3.
Apparently, the CPE phenotype is correlated to NS3 expression,
whereas expression of NS3a (mutAUG1 versus mutAUG1+2)
showed no obvious difference in CPE in BSR cells.
Since BTV mutants lacking NS3 expression showed a smaller
plaque size, this could affect virus growth or release of virus into
the culture medium. Therefore growth of these virus mutants was
studied in BSR and KC cells (Fig. 5a–d). Monolayers were infected
with an MOI of 0.01 and virus titers were determined in
supernatant (released virus) and cells (cell-associated virus) at
different time points after infection. All viruses reached maximum
virus titers in mammalian cells (BSR) of approximately 6–7
10logTCID50/ml at 40 hours post infection (hpi) (Fig. 5a/b).
Maximum virus titers in supernatant for wtBTV1/8(S10) and
mutAUG2 virus coincided with these in the cells, whereas virus
titers for mutAUG1 and mutAUG1+2 levels were still increasing
after 120 hpi. These results indicate that BTV mutants without
NS3 are hampered in release of virus from mammalian cells.
Growth curves in insect cells (KC) showed cell-associated virus
titers increasing rapidly in 20–30 hpi and these virus titers reached
a maximum of approximately 7.8 10logTCID50/ml for wtBTV1/
8(S10), 5.7 for mutAUG1 and mutAUG2, and 4.6 (mutAUG1+2)
(Fig. 5c/d). wtBTV1/8(S10) was released into the supernatant
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from KC cells at 40 hpi to a virus titer of 4.55 10logTCID50/ml
and further increased slowly to maximum virus titers of 5.9
10logTCID50/ml at 120 hpi. MutAUG2 (also expressing NS3)
showed a strongly delayed virus release of 10log 3.6 TCID50/ml in
supernatant at 120 hpi. In contrast, both mutAUG1 and
mutAUG1+2 (not expressing NS3) were not significantly secreted
into the medium. For these mutants, the amount of cell-associated
virus was comparable in the first 24 hours and then continued at a
maximum in the following harvests up to 120 hpi. Apparently,
virus release from insect cells (KC) of BTV mutants without NS3
expression was strongly reduced. In mutAUG2, only NS3 is
expressed and showed a very strong delay in virus release at
120 hpi compared to wtBTV1/8(S10) expressing both NS3 and
NS3a. These results suggest a role of NS3a in virus release from
insect cells.
Discussion
The mechanisms of virus release from the infected cell of
arthropod borne viruses is very intriguing, since it might be linked
to pathogenesis and viremia as well as to transmission of virus
between host and insect vector. Nonstructural proteins NS3 and
NS3a of BTV encoded by Seg-10 are involved in trafficking and
egress of virus [17,18]. The calpactin light chain (S100A10/p11)
binding domain on the N-terminal end of NS3 is involved in
intracellular trafficking of BTV [18], and NS3/NS3a also interacts
with Tsg101 and uses the ESCRT pathway in mammalian cells for
budding [23]. Further, the C-terminal domain interacts with VP2
on the outside of the BTV particle [16].
Here, we used the established reverse genetics system for BTV
[21,24] to investigate the role of motifs and domains of NS3/NS3a
in BTV replication. Intending to express C-terminally truncated
NS3/NS3a proteins, 4-basepairs insertions were introduced at
different positions in the ORF of NS3/NS3a resulting in out-of-
frame mutations. However, generated BTV mutants showed a
Figure 2. Analysis of revertant viruses Sty-rev and BsiWI-rev. (A) anti-VP7 immunostained cells after 2 or 13 days post transfection with BTV1
Seg-1-9 and mutated Seg-10 StyI-filled resulting in revertant virus StyI-rev1 showing CPE at 13 dpt. (B) sequence analysis of Seg-10 amplicons from
StyI-rev1 passages at different time points after transfection. In single letter code, putative translation of all three frames is shown of which the
middle is the ORF of NS3 with the insertion of Alanine (A) in StyI-rev1. Here the analysis is shown by use of a sequence primer located downstream of
the StyI site. Note the mixed sequence at 8 dpt upstream of the filled site due the introduction of the point deletion at the StyI site in a subpopulation
of the fragments. (C) Comparison of the amino acid sequences of NS3 of wtBTV1/8(S10), the 4-basepairs insertions, and the rescued revertant viruses
Sty-rev1, 2 and BsiWI-rev1. Amino acids changes in the regions of the 4-basepairs insertion of the revertant viruses Sty-rev1, 2 and BsiWI-rev1 are in
bold.
doi:10.1371/journal.pone.0085788.g002
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point deletion therewith restoring the expression of NS3/NS3a
with an insertion of one codon at the position of the original 4-
basepairs insertion. For another revertant, the point deletion also
resulted in amino acid mutations upstream the inserted codon
(Fig. 2). Obviously, mutations restored the expression of NS3/
NS3a and this expression is associated with CPE. Thus, despite of
amino acid mutations in NS3/NS3a, including mutations in the
first late domain, expression of NS3/NS3a is highly favorable in
BTV propagation. Apparently, BTV revertants expressing NS3/
NS3a were selected by passing the transfected cells and this
procedure generated faster replicating BTV mutants that over-
grow the original BTV mutant (Fig. 2). This method can be used
to study the role of other regions and domains in NS3/NS3a, and
herewith the mechanism of mutagenesis by the RNA dependent
RNA polymerase of orbivirus.
Revertants of NS3/NS3a mutations suggested a very important
or even essential role of NS3/NS3a. This is in agreement with an
earlier report in which a similar NS3 mutant (named BTVM1 in
that study) was generated using in trans complementation of NS3/
NS3a proteins [18]. Nonetheless, we were able to generate BTV
mutants lacking expression of NS3, NS3a or both, and propagate
these BTV mutants in normal BSR cells (mutAUG1, mutAUG2,
and mutAUG1+2). Moreover, these BTV mutants were analyzed
by several methods to confirm expression of the respective NS3
and NS3a proteins. Besides initiation codons AUG1 and AUG2
for expression of NS3 and NS3a respectively, another eleven in-
frame AUG codons are present in Seg-10. So, it cannot be
excluded that scanning ribosomal subunits could use downstream
located AUG codons as initiation codon resulting in N-terminally
truncated NS3 proteins. We could not detect any NS3 related
proteins from the mutAUG1+2 by immunostaining of fixed cells
and Westernblot analysis indicating the absence of NS3, NS3a or
other NS3 related proteins, provided that binding of antibodies to
these products is not disturbed. We conclude that mutAUG1+2
virus represents BTV with a nontranslated genome segment 10
with respect to NS3/NS3a expression, and that neither NS3 nor
NS3a is essential for virus propagation. Although expression of
Figure 3. Sequence analysis and plaque phenotype of AUG mutant viruses. (A) Sequence analysis of Seg-10 amplicons from AUG mutant
viruses shown in DNASTAR Lasergene Seqman assembly software. The mutated codons are indicated in rectangles (B) Plaque morphology of BSR
cells infected with wtBTV1/8(S10), mutAUG1, mutAUG2 and mutAUG1+2 virus grown under 1% methylcellulose overlay medium are shown. At 2 dpi
cells were fixed and immunostained with anti-VP7 Mab.
doi:10.1371/journal.pone.0085788.g003
Figure 4. Detection of viral proteins of AUG mutant viruses.
Westernblot analysis of expression of NS3 and VP5 in cell lysates from
BSR cells infected with wtBTV1/8(S10) (lane 1), mutAUG1 (lane 2),
mutAUG2 (lane 3), mutAUG1+2 (lane 4) and mock-infected cells (lane 5)
using antibodies against BTV NS3 or VP5.
doi:10.1371/journal.pone.0085788.g004
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other yet unknown gene products by Seg-10 is most unlikely the
existence cannot be ruled out.
Still, the presence of NS3 and NS3a proteins encoded by Seg-10
is strongly conserved in Culicoides arthropod borne orbiviruses
supporting an important role for both of these proteins. The
amino acid sequence between the NS3 and NS3a initiation codons
of orbiviruses is variable in length, but is highly conserved in
length and sequence within studied orbiviruses species like BTV
and AHSV. This region, harboring the calpactin light chain
(S100A10/p11) binding domain essential for intracellular traffick-
ing of BTV in BSR cells, is lacking in NS3a [18]. Obviously, the
main mechanism of egress of non-enveloped viruses is cell lysis,
therewith most likely killing the infected mammalian cell.
However, non-lytic processes of virus release, like budding, have
also been suggested [25,26]. For arthropod borne orbiviruses, cell
lysis has not been observed in insect cells in contrast to cell lysis of
mammalian cells [11,12,13,27]. BTV release from BSR cells is
mainly dependent on CPE through the permeabilization of the
membrane likely induced by NS3 [19], whereas BTV release from
KC cells is dependent on budding [17]. Virus release from BSR
cells is solely dependent on NS3 expression, whereas virus release
from KC cells is strongly reduced by either lack of NS3, NS3a or
both proteins (Figure 5). Since virus release from insect cells occurs
by budding, these results suggest that both proteins are involved in
budding, and thus also suggests a specific role for NS3a. This
might also explain the conserved second start codon in Seg-10 of
arthropod borne orbivirus species. Further research is needed to
unravel the specific role of each of these non-structural proteins in
virus release from insect cells.
Generally, replication of all BTV mutants was similar to
wtBTV1/8(S10) in KC and BSR cells for the first 24 hours post
infection but after this period, differences were observed in
released virus as well as in cell-associated fractions. Inefficient
release of virus appeared to coincide with lower virus titers in cells
in both cell types. Thus, the total virus production is lower for
mutants disturbed in virus release. Apparently, accumulation of
virus in the cytosol by lack of transport to the membrane and
subsequent egress of virus will decrease or delay re-infections after
the first round of infection. However, this accumulation could also
hinder BTV replication in the infected cell. For BSR cells, a lower
virus titer in the supernatant and cell-associated fraction was also
associated with a significantly delayed but clear CPE and reduced
plaque size. Celma et al. [18] did not observe CPE of BSR cells
infected with BTVM14, which is similar to our mutAUG1 virus,
and these authors have suggested a blockade in BTV replication
late in infection, since all other viral processes were accomplished
like protein translation, genome replication and assembly of viral
cores [18]. We indeed suggest that disturbing the virus release also
reduce BTV replication in BSR cells, and causes delayed CPE and
reduced plaque size. However, this disturbed virus release is not a
complete blockade, since mutant viruses were propagated, and
successfully passed in normal cell lines.
Obviously, NS3 plays an important role in BTV release from
mammalian cells, whereas both NS3 and NS3a are important for
release from KC cells. However, both NS3 and NS3a can be
deleted and resulted in replicating BTV without NS3/NS3a
expression. In conclusion, mutAUG1+2 virus can still cause CPE,
and we assume that CPE is the main mechanism of egress to the
Figure 5. Replication kinetics of AUGmutant viruses on mammalian and insect cells. Virus growth and virus release of AUG mutant viruses
grown on BSR cells and KC cells infected in duplicate with wtBTV1/8 (S10), mutAUG1, mutAUG2 and mutAUG1+2 viruses and harvested at indicated
time points post infection. Virus titers were determined in supernatant and in cells by endpoint dilution, and the mean values are expressed as
10logTCID50/ml. (A) released virus from BSR cells (upper left panel) or (B) BSR cell-associated virus (upper right panel). (C) released virus from KC cells
(lower left panel) or (D) KC cell-associated virus (lower right panel).
doi:10.1371/journal.pone.0085788.g005
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medium of BTV lacking NS3/NS3a protein. NS3 represents
viroporin-like properties [19]. Viroporins compose a group of
small hydrophobic transmembrane proteins that can form
hydrophilic pores through lipid bilayers. Viroporins have been
implicated in promoting virus release and in affecting cellular
functions including protein trafficking and membrane permeability
thereby promoting viral pathogenicity. Compounds interfering
with the permeabilizing ability of viroporins inhibit virus
production [28,29]. This is in agreement with our results and
suggests that NS3/NS3a of orbiviruses is a virulence marker as
shown [30]. Moreover, viroporin-defective viruses are being
explored as live-attenuated vaccines [31].
The finding of BTV propagation without NS3 or NS3a enables
further research using reverse genetics on translation and functions
of NS3 and NS3a in mammalian and insect cells, and in the host
and the insect vector. Further, BTV with a nontranslated segment
- since NS3 and NS3a are the only known gene products encoded
by Seg-10 -, enables research to study the role of RNA sequences
in BTV replication without interference of gene products.
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